Regeneration Next: Toward Heart Stem Cell Therapeutics

Cell Stem Cell

Volumn 5, Issue 4, 2009, Pages 364-377

  Hansson, Emil M ^a   Lindsay, Mark E ^a,b   Chien, Kenneth R ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOVASCULAR DISEASE; CASE STUDY; CELL REGENERATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CYTOLOGY; EMBRYONIC STEM CELL; EXPERIMENTAL STUDY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART FAILURE; HEART MUSCLE CELL; HEART STEM CELL THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

CARDIOVASCULAR DISEASES; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 70349330763     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2009.09.004     Document Type: Review

References (110)

1. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., and Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
2. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T., and Ericson J. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124 (2006) 393-405
3. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
4. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
5. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., et al. Evidence for cardiomyocyte renewal in humans. Science 324 (2009) 98-102
6. Billingham R.E., and Brent L. A simple method for inducing tolerance of skin homografts in mice. Transplant. Bull. 4 (1957) 67-71
7. Blelloch R., Venere M., Yen J., and Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1 (2007) 245-247
8. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., Roberts D.J., Domian I.J., and Chien K.R. Human ISL1 primordial heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 10.1038/nature08191 in press
9. Buckingham M., Meilhac S., and Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 6 (2005) 826-835
10. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., and Evans S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5 (2003) 877-889
11. Cai C.L., Martin J.C., Sun Y., Cui L., Wang L., Ouyang K., Yang L., Bu L., Liang X., Zhang X., et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 454 (2008) 104-108
12. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., Zhang J.J., Chunhua R.Z., Liao L.M., Lin S., and Sun J.P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94 (2004) 92-95
13. Chien K.R. Stem cells: Lost in translation. Nature 428 (2004) 607-608
14. Chien K.R. Regenerative medicine and human models of human disease. Nature 453 (2008) 302-305
15. Chien K.R., Domian I.J., and Parker K.K. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 322 (2008) 1494-1497
16. Conway S.J., Henderson D.J., and Copp A.J. Pax3 is required for cardiac neural crest migration in the mouse: Evidence from the splotch (Sp2H) mutant. Development 124 (1997) 505-514
17. Couzin J. Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells. Science 323 (2009) 568
18. David R., Brenner C., Stieber J., Schwarz F., Brunner S., Vollmer M., Mentele E., Muller-Hocker J., Kitajima S., Lickert H., et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat. Cell Biol. 10 (2008) 338-345
19. Davis R.L., Weintraub H., and Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51 (1987) 987-1000
20. Deb A., Wang S., Skelding K.A., Miller D., Simper D., and Caplice N.M. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 107 (2003) 1247-1249
21. Dixon J.A., and Spinale F.G. Large animal models of heart failure: A critical link in the translation of basic science to clinical practice. Circ. Heart Fail. 2 (2009) 262-271
22. Drenckhahn J.D., Schwarz Q.P., Gray S., Laskowski A., Kiriazis H., Ming Z., Harvey R.P., Du X.J., Thorburn D.R., and Cox T.C. Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development. Dev. Cell 15 (2008) 521-533
23. Feinberg A.W., Feigel A., Shevkoplyas S.S., Sheehy S., Whitesides G.M., and Parker K.K. Muscular thin films for building actuators and powering devices. Science 317 (2007) 1366-1370
24. Gatti R.A., Meuwissen H.J., Allen H.D., Hong R., and Good R.A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2 (1968) 1366-1369
25. Ghostine S., Carrion C., Souza L.C., Richard P., Bruneval P., Vilquin J.T., Pouzet B., Schwartz K., Menasche P., and Hagege A.A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106 (2002) I131-I136
26. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., Noiseux N., Zhang L., Pratt R.E., Ingwall J.S., and Dzau V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11 (2005) 367-368
27. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., and Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
28. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., Beard C., Brambrink T., Wu L.C., Townes T.M., and Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318 (2007) 1920-1923
29. Hoerstrup S.P., Kadner A., Breymann C., Maurus C.F., Guenter C.I., Sodian R., Visjager J.F., Zund G., and Turina M.I. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann. Thorac. Surg. 74 (2002) 46-52
30. Hsieh P.C., Segers V.F., Davis M.E., MacGillivray C., Gannon J., Molkentin J.D., Robbins J., and Lee R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13 (2007) 970-974
31. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K., and Goodell M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107 (2001) 1395-1402
32. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
33. Jessup M., and Brozena S. Heart failure. N. Engl. J. Med. 348 (2003) 2007-2018
34. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., and Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458 (2009) 771-775
35. Kang H.J., Lee H.Y., Na S.H., Chang S.A., Park K.W., Kim H.K., Kim S.Y., Chang H.J., Lee W., Kang W.J., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 (2006) I145-I151
36. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., and Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108 (2001) 407-414
37. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., and Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4 (2009) 472-476
38. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S., and Epstein S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109 (2004) 1543-1549
39. Kirouac D.C., and Zandstra P.W. The systematic production of cells for cell therapies. Cell Stem Cell 3 (2008) 369-381
40. Kiuru M., Boyer J.L., O'Connor T.P., and Crystal R.G. Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell 4 (2009) 289-300
41. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
42. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25 (2007) 1015-1024
43. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat. Biotechnol. 23 (2005) 845-856
44. Lau D., Ogbogu U., Taylor B., Stafinski T., Menon D., and Caulfield T. Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 3 (2008) 591-594
45. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., Lin L.Z., Cai C.L., Lu M.M., Reth M., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
46. Lensch M.W., Schlaeger T.M., Zon L.I., and Daley G.Q. Teratoma formation assays with human embryonic stem cells: A rationale for one type of human-animal chimera. Cell Stem Cell 1 (2007) 253-258
47. Lepilina A., Coon A.N., Kikuchi K., Holdway J.E., Roberts R.W., Burns C.G., and Poss K.D. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127 (2006) 607-619
48. Li B., Zeng Q., Wang H., Shao S., Mao X., Zhang F., Li S., and Guo Z. Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coron. Artery Dis. 18 (2007) 221-227
49. Li J., Liu K.C., Jin F., Lu M.M., and Epstein J.A. Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126 (1999) 2495-2503
50. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 367 (2006) 1747-1757
51. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1199-1209
52. Maherali N., and Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3 (2008) 595-605
53. Martin C.M., Meeson A.P., Robertson S.M., Hawke T.J., Richardson J.A., Bates S., Goetsch S.C., Gallardo T.D., and Garry D.J. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265 (2004) 262-275
54. Martin-Puig S., Wang Z., and Chien K.R. Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2 (2008) 320-331
55. Marx J.L. 1980 Nobel prize in physiology or medicine. Science 210 (1980) 621-623
56. Meissner A., Wernig M., and Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25 (2007) 1177-1181
57. Meluzin J., Janousek S., Mayer J., Groch L., Hornacek I., Hlinomaz O., Kala P., Panovsky R., Prasek J., Kaminek M., et al. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int. J. Cardiol. 128 (2008) 185-192
58. Menasche P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., Vilquin J.T., Marolleau J.P., Seymour B., Larghero J., et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
59. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., Schwartz K., Vilquin J.T., and Marolleau J.P. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
60. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., Bel A., Sarateanu S., Scorsin M., Schwartz K., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41 (2003) 1078-1083
61. Mettler B.A., Sales V.L., Stucken C.L., Anttila V., Mendelson K., Bischoff J., and Mayer Jr. J.E. Stem cell-derived, tissue-engineered pulmonary artery augmentation patches in vivo. Ann. Thorac. Surg. 86 (2008) 132-140
62. Min J.Y., Yang Y., Converso K.L., Liu L., Huang Q., Morgan J.P., and Xiao Y.F. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92 (2002) 288-296
63. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., Qyang Y., Bu L., Sasaki M., Martin-Puig S., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 (2006) 1151-1165
64. Morrison S.J. Stem cell potential: Can anything make anything?. Curr. Biol. 11 (2001) R7-R9
65. Muller-Ehmsen J., Whittaker P., Kloner R.A., Dow J.S., Sakoda T., Long T.I., Laird P.W., and Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. 34 (2002) 107-116
66. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
67. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
68. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., Taneera J., Fleischmann B.K., and Jacobsen S.E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10 (2004) 494-501
69. Oberpriller J.O., and Oberpriller J.C. Response of the adult newt ventricle to injury. J. Exp. Zool. 187 (1974) 249-253
70. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100 (2003) 12313-12318
71. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
72. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., and Taylor D.A. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat. Med. 14 (2008) 213-221
73. Ott M.G., Schmidt M., Schwarzwaelder K., Stein S., Siler U., Koehl U., Glimm H., Kuhlcke K., Schilz A., Kunkel H., et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12 (2006) 401-409
74. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., and Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
75. Passier R., Denning C., and Mummery C. Cardiomyocytes from human embryonic stem cells. Handb. Exp. Pharmacol. (2006) 101-122
76. Passier R., van Laake L.W., and Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 453 (2008) 322-329
77. Poss K.D., Wilson L.G., and Keating M.T. Heart regeneration in zebrafish. Science 298 (2002) 2188-2190
78. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., Kajstura J., Leri A., and Anversa P. Chimerism of the transplanted heart. N. Engl. J. Med. 346 (2002) 5-15
79. Qyang Y., Martin-Puig S., Chiravuri M., Chen S., Xu H., Bu L., Jiang X., Lin L., Granger A., Moretti A., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 1 (2007) 165-179
80. Reinecke H., Poppa V., and Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34 (2002) 241-249
81. Rubart M., Soonpaa M.H., Nakajima H., and Field L.J. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J. Clin. Invest. 114 (2004) 775-783
82. Schachinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., Abolmaali N.D., Vogl T.J., Hofmann W.K., Martin H., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44 (2004) 1690-1699
83. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
84. Shieh S.J., and Vacanti J.P. State-of-the-art tissue engineering: From tissue engineering to organ building. Surgery 137 (2005) 1-7
85. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Isogai N., Langer R., Vacanti J.P., and Mayer Jr. J.E. Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 115 (1998) 536-545
86. Srivastava D. Making or breaking the heart: From lineage determination to morphogenesis. Cell 126 (2006) 1037-1048
87. Stoller J.Z., and Epstein J.A. Cardiac neural crest. Semin. Cell Dev. Biol. 16 (2005) 704-715
88. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., Kogler G., and Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
89. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
90. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
91. Takeuchi J.K., and Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459 (2009) 708-711
92. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., Glower D.D., and Kraus W.E. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat. Med. 4 (1998) 929-933
93. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., and Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
94. Thomas E.D., Lochte Jr. H.L., Cannon J.H., Sahler O.D., and Ferrebee J.W. Supralethal whole body irradiation and isologous marrow transplantation in man. J. Clin. Invest. 38 (1959) 1709-1716
95. Thomas E.D., Lochte Jr. H.L., Lu W.C., and Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 257 (1957) 491-496
96. Thomas E.D., Storb R., Clift R.A., Fefer A., Johnson L., Neiman P.E., Lerner K.G., Glucksberg H., and Buckner C.D. Bone-marrow transplantation (second of two parts). N. Engl. J. Med. 292 (1975) 895-902
97. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
98. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 (2006) 1414-1421
99. van Laake L.W., Passier R., Monshouwer-Kloots J., Verkleij A.J., Lips D.J., Freund C., den Ouden K., Ward-van Oostwaard D., Korving J., Tertoolen L.G., et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Rev. 1 (2007) 9-24
100. van Ramshorst J., Bax J.J., Beeres S.L., Dibbets-Schneider P., Roes S.D., Stokkel M.P., de Roos A., Fibbe W.E., Zwaginga J.J., Boersma E., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 301 (2009) 1997-2004
101. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
102. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458 (2009) 766-770
103. Wu S.M., Fujiwara Y., Cibulsky S.M., Clapham D.E., Lien C.L., Schultheiss T.M., and Orkin S.H. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127 (2006) 1137-1150
104. Yamanaka S. A fresh look at iPS cells. Cell 137 (2009) 13-17
105. Yu J., Hu K., Smuga-Otto K., Tian S., and Stewart R. Slukvin, II, and Thomson, J. A Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences. Science 324 (2009) 797-801
106. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
107. Zhou B., Ma Q., Rajagopal S., Wu S.M., Domian I., Rivera-Feliciano J., Jiang D., von Gise A., Ikeda S., Chien K.R., and Pu W.T. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454 (2008) 109-113
108. Zhou Q., Brown J., Kanarek A., Rajagopal J., and Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455 (2008) 627-632
109. Zhou Q., Law A.C., Rajagopal J., Anderson W.J., Gray P.A., and Melton D.A. A multipotent progenitor domain guides pancreatic organogenesis. Dev. Cell 13 (2007) 103-114
110. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., Hess A., Budinsky L., Brune K., Michaelis B., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12 (2006) 452-458